Search

Author/Creator Shimokawa, Kenichiro

1. Development of protein degradation inducers of oncogenic BCR‐ABL protein by conjugation of ABL kinase inhibitors and IAP ligands. Issue 8 (19th June 2017)

Authors:
Shibata, Norihito; Miyamoto, Naoki; Nagai, Katsunori; Shimokawa, Kenichiro; Sameshima, Tomoya; Ohoka, Nobumichi; Hattori, Takayuki; Imaeda, Yasuhiro; Nara, Hiroshi; Cho, Nobuo; Naito, Mikihiko
Journal:
Cancer science
Issue:
Volume 108:Issue 8(2017)
Page Start:
1657
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Fragment-based drug discovery of potent and selective MKK3/6 inhibitors. Issue 3 (1st February 2016)

Authors:
Adams, Mark; Kobayashi, Toshitake; Lawson, J. David; Saitoh, Morihisa; Shimokawa, Kenichiro; Bigi, Simone V.; Hixon, Mark S.; Smith, Christopher R.; Tatamiya, Takayuki; Goto, Masayuki; Russo, Joseph; Grimshaw, Charles E.; Swann, Steven
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 26:Issue 3(2016)
Page Start:
1086
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Fragment-based drug discovery of potent and selective MKK3/6 inhibitors. Issue 3 (1st February 2016)

Authors:
Adams, Mark; Kobayashi, Toshitake; Lawson, J. David; Saitoh, Morihisa; Shimokawa, Kenichiro; Bigi, Simone V.; Hixon, Mark S.; Smith, Christopher R.; Tatamiya, Takayuki; Goto, Masayuki; Russo, Joseph; Grimshaw, Charles E.; Swann, Steven
Journal:
Bioorganic & medicinal chemistry letters
Issue:
Volume 26:Issue 3(2016)
Page Start:
1086
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search